Combination carmustine (BCNU) and dianhydrogalactitol in the treatment of primary brain tumors recurring after irradiation.
D000328:Adult; D000368:Aged; D001254:Astrocytoma / Q000188:drug therapy* / Q000532:radiotherapy; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy; D002330:Carmustine / Q000008:administration & dosage* / Q000009:adverse effects; D003961:Dianhydrogalactitol / Q000008:administration & dosage* / Q000009:adverse effects; D004359:Drug Therapy, Combination; D005069:Evaluation Studies as Topic; D005260:Female; D005910:Glioma / Q000188:drug therapy* / Q000532:radiotherapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy / Q000532:radiotherapy; D009837:Oligodendroglioma / Q000188:drug therapy* / Q000532:radiotherapy; D011379:Prognosis; D013402:Sugar Alcohols / Q000008:administration & dosage*
D013402:Sugar Alcohols; D003961:Dianhydrogalactitol; D002330:Carmustine